Christina Anderlind, M.D.
NPI 1497729628 · Pulmonary Disease Physician · Boston, MA
Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1497729628
- Entity type
- Individual
- Primary specialty
- Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- No
- License
- 227948 (MA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
20 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
629 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 120 | $150 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233 | 84 | $124 |
| Prolonged Office Or Other Outpatient Evaluation and Management Service(s) Beyond the Maximum Required Time of the Primary Procedure Which Has Been Selected Using Total Time on the Date of the Primary Service; Each Additional 15 Minutes By the Physician OrG2212 | 70 | $33 |
| Critical Care, First 30-74 Minutes99291 | 55 | $220 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211 | 55 | $17 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 15 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Fluticasone/Vilanterolbrand: Breo Ellipta | 50 | — |
| Prednisone | 47 | 16 |
| Umeclidinium Bromidebrand: Incruse Ellipta | 45 | — |
| Montelukast Sodium | 36 | 13 |
| Mycophenolate Mofetil | 35 | — |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 33 | 13 |
| Fluticasone/Umeclidin/Vilanter |
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-02-14
- Last updated
- 2022-08-04
- Certified
- 2022-08-04
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.